Clinical Research Directory
Browse clinical research sites, groups, and studies.
Multimorbidity and Sarcopenia Feasibility Study in Chronic Kidney Disease
Sponsor: University Hospitals of Derby and Burton NHS Foundation Trust
Summary
The aim of this research study is to look at the body composition (such as muscle and fat) in people with chronic kidney disease (CKD) and comparing it with body composition is people without CKD. The investigators currently understand loss of muscle function and mass (sarcopenia) affect the general health of people as they age, but this process seems to be more common, accelerated, and occurs earlier in people with CKD. There is limited evidence in this area, and we believe that if we understand when and how sarcopenia affects people with CKD, investigators can guide future trials and treatments to help treat sarcopenia, and in turn improve quality of life and health outcomes in people with CKD.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
80
Start Date
2024-02-12
Completion Date
2025-11-02
Last Updated
2025-09-05
Healthy Volunteers
Yes
Conditions
Interventions
Cystatin C eGFR
Cystatin C eGFR is not used routinely currently in clinical practice in the UK. It involved a blood test to analyse Cystatin C.
Bioimpedance Analysis (Body composition analysis)
Participants will stand on a bioimpedance analysis machine which will measure different components of body composition
Locations (1)
University Hospitals of Derby and Burton NHS Foundation Trust
Derby, United Kingdom